Van Tol HH - Search Results

1

A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission.

Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, MacDonald JF. Kotecha SA, et al. Among authors: van tol hh. Neuron. 2002 Sep 12;35(6):1111-22. doi: 10.1016/s0896-6273(02)00859-0. Neuron. 2002. PMID: 12354400 Free article.

2

The dopamine D(4) receptor: one decade of research.

Oak JN, Oldenhof J, Van Tol HH. Oak JN, et al. Among authors: van tol hh. Eur J Pharmacol. 2000 Sep 29;405(1-3):303-27. doi: 10.1016/s0014-2999(00)00562-8. Eur J Pharmacol. 2000. PMID: 11033337 Review.

3

Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor.

Oak JN, Lavine N, Van Tol HH. Oak JN, et al. Among authors: van tol hh. Mol Pharmacol. 2001 Jul;60(1):92-103. doi: 10.1124/mol.60.1.92. Mol Pharmacol. 2001. PMID: 11408604

4

D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent.

Beazely MA, Tong A, Wei WL, Van Tol H, Sidhu B, MacDonald JF. Beazely MA, et al. J Neurochem. 2006 Sep;98(5):1657-63. doi: 10.1111/j.1471-4159.2006.04064.x. Epub 2006 Jul 31. J Neurochem. 2006. PMID: 16879713 Free article.

5

Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis.

Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HH. Van Craenenbroeck K, et al. Among authors: van tol hh. J Biol Chem. 2005 May 13;280(19):19350-7. doi: 10.1074/jbc.M414043200. Epub 2005 Mar 8. J Biol Chem. 2005. PMID: 15755724 Free article.

6

SH3 binding domains in the dopamine D4 receptor.

Oldenhof J, Vickery R, Anafi M, Oak J, Ray A, Schoots O, Pawson T, von Zastrow M, Van Tol HH. Oldenhof J, et al. Among authors: van tol hh. Biochemistry. 1998 Nov 10;37(45):15726-36. doi: 10.1021/bi981634+. Biochemistry. 1998. PMID: 9843378

7

G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase.

Lavine N, Ethier N, Oak JN, Pei L, Liu F, Trieu P, Rebois RV, Bouvier M, Hebert TE, Van Tol HH. Lavine N, et al. Among authors: van tol hh. J Biol Chem. 2002 Nov 29;277(48):46010-9. doi: 10.1074/jbc.M205035200. Epub 2002 Sep 23. J Biol Chem. 2002. PMID: 12297500 Free article.

8

Cloning of a G protein-activated inwardly rectifying potassium channel from human cerebellum.

Schoots O, Yue KT, MacDonald JF, Hampson DR, Nobrega JN, Dixon LM, Van Tol HH. Schoots O, et al. Among authors: van tol hh. Brain Res Mol Brain Res. 1996 Jul;39(1-2):23-30. doi: 10.1016/0169-328x(95)00349-w. Brain Res Mol Brain Res. 1996. PMID: 8804710

9

Dopamine receptor pharmacology.

Seeman P, Van Tol HH. Seeman P, et al. Among authors: van tol hh. Trends Pharmacol Sci. 1994 Jul;15(7):264-70. doi: 10.1016/0165-6147(94)90323-9. Trends Pharmacol Sci. 1994. PMID: 7940991 Review.

10

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.

Wilson JM, Sanyal S, Van Tol HH. Wilson JM, et al. Among authors: van tol hh. Eur J Pharmacol. 1998 Jun 26;351(3):273-86. doi: 10.1016/s0014-2999(98)00312-4. Eur J Pharmacol. 1998. PMID: 9721018 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page